Are you struggling to manage acid reflux symptoms?
If so, consider joining the TRIUMpH study, a clinical trial for people with erosive esophagitis (EE) investigating a new potential treatment. Study participation helps impact the progression of erosive esophagitis (EE) research.
Erosive Esophagitis (EE)
The TRIUMpH clinical research study is researching a study medication for people with erosive esophagitis (EE). The purpose of this study is to measure the safety and effectiveness of the study medication in people with EE.
Study information:
Condition: Erosive Esophagitis (EE)
Location: Las Vegas, Nevada
Duration: Approximately32-38 weeks
Participation: Up to 13 visits
Compensation: Up to $1300
Eligibility:
Age 18 or older
Must experience symptoms consistent with erosive esophagitis (EE) including:
Heartburn (acid reflux)
Regurgitation
And/or esophageal pain
Able to undergo an upper GI endoscopy
Other study requirements apply.
Participants may receive:
Compensation up to $1300
Study-related healthcare and medication at no cost
Evaluations of your acid reflux symptoms by a local physician specialist
Opportunity to help advance a new potential treatment option for EE
Get started today.
You are not committed to participate in a study by completing this form. Participation is voluntary, and you may leave at any time if you change your mind.
What is erosive esophagitis?
Erosive esophagitis is an extreme form of acid reflux. It occurs when stomach acid flows backward into the esophagus, causing pain and irritation. People with EE can also have damage to the esophagus.
The main symptoms of EE are a burning sensation in the chest (heartburn) and uncomfortable movement of material from the stomach through the esophagus (regurgitation).
Some people do not respond to the current treatments available for EE. The TRIUMpH research study is researching a study medication to potentially provide another option for people with EE.
Information provided by: www.triumphclinicaltrial.com/